Target intelligence / Profile preview

LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 3 (LSM3P3)

Target
LSM3P3
Molecular classification
Pseudogene
01

Overview

LSM3P3, or "LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 3," is a pseudogene identified in Homo sapiens[9]. A pseudogene is a segment of DNA that closely resembles a known gene but is generally considered nonfunctional and does not encode a protein product[10]. Unlike its functional parental gene LSM3, which plays a role in pre-mRNA splicing and mRNA degradation, LSM3P3 does not encode a functional protein and is not known to have a confirmed biological function or disease association[9][10]. No evidence supports its use as a therapeutic target, biomarker, or safety concern. The precise function of most pseudogenes—including LSM3P3—is often unclear. Some pseudogenes can have regulatory effects at the RNA level (such as competing endogenous RNA activity), but there is no specific evidence for such a role for LSM3P3 in current sources[9][10]. The designation "pseudogene" means it is unlikely to have a direct role as a molecular target relevant to drug discovery or clinical biomarker use[10]. LSM3P3 is not a therapeutic target, lacks direct biological or disease relevance, and its listing as a "receptor" or target is incorrect. It should be classified primarily as a pseudogene in structured databases[9][10].

02

Mechanism of action

None (not a target of known drugs)

03

Biological functions

None (no known coding function; classified as a pseudogene)
04

Disease associations

None (no direct disease association or therapeutic implication reported for this pseudogene)
05

Safety considerations

None
06

Biomarkers

None established

Beyond the preview

Go deeper on LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 3 (LSM3P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated pseudogene 3 (LSM3P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call